Recent News and Articles on the Keywords: hot + flash + 0.20  Related to the article below (Last Update: 8/5/2008)

Depomed Reports Second Quarter 2008 Financial Results
StreetInsider.com (subscription), MI - Jul 31, 2008
We anticipate starting the Phase 3 trials in menopausal hot flashes in the third quarter, as we had a successful end-of-Phase 2 meeting with the FDA in June ...
Source: Google News

Effect of Soy Phytoestrogens on Hot Flashes in Postmenopausal Women With Breast Cancer: A Randomized … -
CL Van Patten, IA Olivotto, GK Chambers, KA Gelmon … - Journal of Clinical Oncology, 2002 - jcojournal.org
... window], Table 4. Difference in Mean (%) Hot Flashes From Baseline ... perceived a marginal
decrease in hot flash number in ... 0.29 ? 0.85 ?mol/L v 0.20 ? 0.64 ?mol ...

Reduced thermoregulatory null zone in postmenopausal women with hot flashes. -
RR Freedman, W Krell - American Journal of Obstetrics & Gynecology, 1999 - pt.wkhealth.com
... C versus 1.5[degree sign]C +/- 0.20[degree sign ... Hot flashes are the most common symptom
of the climacteric ... A hot flash is similar to a heat dissipation response ...

Physiology of hot flashes -
RR Freedman - American Journal of Human Biology, 2001 - doi.wiley.com
... 0.18 1.5 ? 0.20 P value 0.0003 0.02 0.0006 a P values for group differences, unpaired
t-tests. PHYSIOLOGY OF HOT FLASHES 461 Page 10. flash periods (36.70 ...

Hot Flashes in the Late Reproductive Years: Risk Factors for African American and Caucasian Women -
EW Freeman, MD Sammel, JA Grisso, M Battistini, B … - Journal of Women's Health & Gender-Based Medicine, 2001 - liebertonline.com
... the physiological events of the hot flash (ie, peripheral ... tween hot flashes
(yes/no) and other variables. ... with associated variables (p , 0.20) consid- ered for ...

[PDF] An Embedded 90nm SONOS Flash EEPROM Utilizing Hot Electron Injection Programming and 2-Sided Hot -
EJ Prinz, GL Chindalore, K Harber, CM Hong, CB Li, … - Motorola Embedded Memory Center, Date Unknown - freescale.com
... In the Flash EEPROM module, the bitcells are arranged in a ... Injection hot hole injection
from drain primary hot el. ... 0.18?m 0.20?m 0.22?m 0.24?m 0.26?m 0.28 ...

Sexual Functioning in Long-Term Breast Cancer Survivors Treated with Adjuvant Chemotherapy -
JA Broeckel, CL Thors, PB Jacobsen, M Small, CE … - Breast Cancer Research and Treatment, 2002 - Springer
... 0.31), depression (r = 0.27), hot flashes, (r = 0 ... 0.04 Oopherectomy (yes/no) -0.21
Hot flash severity ratings ... 0.23 Depression (CES-D) 0.20 Marital functioning ...

Vasomotor Flushes -
B WALSH, I SCHIFF - Annals of the New York Academy of Sciences, 1990 - Blackwell Synergy
... A dose-response relationship between estrogen dose and hot flash frequency was ... of
a 0.025-mg dose reduced flashes by 40 ... by 53%; 0.10 mg, by 83%; and 0.20 mg, by ...

Nonestrogen Treatment Modalities for Vasomotor Symptoms Associated with Menopause -
SE Fugate, CO Church - The Annals of Pharmacotherapy, 2004 - Harvey Whitney Books
... increased to a median of 0.20 ng/mL. ... double-blind study of 165 postmenopausal women
with hot flashes. 32 Hot flash composite score was significantly reduced in ...

… the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause. -
JE Lewis, LA Nickell, LU Thompson, JP Szalai, A … - Menopause, 2006 - menopausejournal.com
... physical; -0.21, P = 0.14; sexual, -0.19, P = 0.20). ... had no effect on perceived severity
of hot flashes. ... studies have concluded that hot flash severity is ...

Effects of isoflavone supplements on bone metabolic markers and climacteric symptoms in Japanese … -
S Uesugi - BioFactors, 2004 - IOS Press
... Genistein 0.23 (0.12, 0.39) 0.20 (0.13, 0.48) 0.10 ... after the IF treatment in hot
flashes (p = 0.005 ... showed improvement from the baseline (hot flash; p = 0.027 ...

Source: Google Scholar
 
 

Hot flash from the boardroom

  When menopausal hot flashes caused sweat to run down Donna Cook's face during business meetings, she joked to concerned colleagues, "I'm having my personal summer."

But for executives like Cook, menopause symptoms such as profuse sweating, nasty mood swings and memory lapses aren't funny.

Cook, 54, felt self-conscious when she had to blot up sweat while giving presentations at System Planning Corp., an Arlington, Va., firm that does scientific research and government-contract work.

She said she would awaken several times a night in drenching sweats after she stopped taking hormone-replacement medication, which she had been on for about 10 years.

"I would oversleep in the morning. I'd miss the alarm. I'd be late for work. I constantly felt like I was playing catch-up," she said. Sometimes, she had trouble remembering how to do routine duties.

Two years later, her symptoms are less frequent and severe, but her problem points to the embarrassment and loss of confidence suffered by many women executives at midlife.

 

A survey of the National Association of Female Executives sponsored by the maker of a menopause drug indicated 95 percent of the 843 respondents had suffered from the physical symptoms of menopause.

Tips for coping


Ideas and resources for dealing with menopause symptoms:

Discuss your symptoms and treatment options with your doctor. Go prepared with a list of questions and tell the doctor about any vitamins, herbs and medicines you are taking.

Stick to a healthful diet.

Get plenty of exercise and try to diversify the type of exercise. Try yoga, meditation or other relaxation methods.

Do research before taking any herbal supplements or alternative menopause treatments, as they are not approved or regulated by the government.

To order a new National Institutes of Health brochure, "Facts About Menopausal Hormone Therapy," call 301-592-8573.

Helpful Web sites

The North American Menopause Society: www.menopause.org

National Women's Health Resource Center: www.healthywomen.org

National Center for Complementary and Alternative Medicine: http://nccam.nih.gov/

 
Google
Web www.iconocast.com
 

Insomnia, night sweats and daytime hot flashes were reported as the most vexing problems, and 56 percent said they deal with symptoms daily. Nearly eight out of 10 reported mental or emotional symptoms such as forgetfulness and irritability.

Forty-one percent had used hormone pills such as Premarin or Prempro to control symptoms.

About half of the women reported lack of sexual desire and painful intercourse due to vaginal dryness. That could explain why emotional well-being and romantic relationships were ranked as the two areas most affected by menopause symptoms, ahead of professional life, said Dr. James Simon, a gynecologist and menopause specialist at George Washington University in Washington, D.C., who helped design the survey questionnaire.

Plenty of earlier studies have examined how menopause affects women in general, said Simon, but "a generation ago, there weren't enough female executives to bother" doing a survey of that group.

He said menopause symptoms may be more prevalent because of the growing obesity problem. "Fatter women are more likely to have hot flashes than thinner women," he explained.

Simon said he was not compensated for the survey by Barr Laboratories, of Woodcliff Lake, N.J. The company makes Cenestin, a synthetic, plant-derived prescription drug for menopause symptoms. The survey was conducted online by pollster Harris Interactive in February.

Amy Niles, president of the National Women's Health Resource Center in Red Bank, N.J., said past educational campaigns about menopause have not targeted women in the work force. They are more likely than their mothers to have to deal with menopause.

"I think we've made great improvements over the last few years in creating awareness that this is a significant issue" that women should discuss with their doctors, Niles said.

Dr. Lauren Streicher, a gynecologist at Northwestern Memorial Hospital in Chicago and author of "The Essential Guide to Hysterectomy," which addresses menopause, said her lower-income, less-educated patients are more likely to accept the strains of menopause as just another big bump in life. Her well-educated professional patients are more likely to seek help and often complain about lack of sleep, which leaves them less motivated and less focused at work.

"This has an incredible impact on their ability to function in the corporate world," she said.

Streicher said many women were confused and scared of hormone therapy after federal researchers reported in 2002 that estrogen-progestin pills sold as Prempro could increase risks for heart attacks, breast cancer and strokes. Many doctors still recommend short-term hormone treatment.

"In an executive position ... you have to look your best," and project a calm, focused and capable image, said Rosalie Roberts, a 61-year-old survey participant who owns an Omaha, Neb., public-relations business.

She had moderate symptoms until several years ago but occasionally would sweat enough during meetings that she would head to the restroom during breaks.

"In my business, that's very, very unfortunate," Roberts said.

 

Continue News With: H2 ; H3 ; H4 ; H5 ; H6 ; H7 ; H8 ; H9 ; H9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 © 2002-2006

Keywords:

Contact Iconocast

Home Page